tirzepatide discontinuation weight regain study Trajectory of after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression Weight regain after the withdrawal

It's also important to explain to patients that GLP-1 and GIP medications influence appetite and brain reward pathways, which might contribute to mood fluctuations

Understanding Tirzepatide Tirzepatide, an FDA-approved weight loss injection, has made significant strides in addressing weight management issues

These researchers pointed to cost, too, but they also hypothesized that patients were only looking for a quick fix when using glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Novo Nordisks brand names Wegovy and Ozempic

A 1 mg dose draws 0.2 mL (20 units on a U-100 syringe), and a 0.5 mg dose draws 0.1 mL (10 units)